Characterization of Hemodynamically Stable Acute Heart Failure Patients Requiring a Critical Care Unit Admission: Derivation, Validation, and Refinement of a Risk Score
Overview
Authors
Affiliations
Background: Most patients with acute heart failure (AHF) admitted to critical care units (CCUs) are low acuity and do not require CCU-specific therapies, suggesting that they could be managed in a lower-cost ward environment. This study identified the predictors of clinical events and the need for CCU-specific therapies in patients with AHF.
Methods: Model derivation was performed using data from patients in the ASCEND-HF trial cohort (n=7,141), and the Acute Heart Failure Emergency Management community-based registry (n=666) was used to externally validate the model and to test the incremental prognostic utility of 4 variables (heart failure etiology, troponin, B-type natriuretic peptide [BNP], ejection fraction) using net reclassification index and integrated discrimination improvement. The primary outcome was an in-hospital composite of the requirement for CCU-specific therapies or clinical events.
Results: The primary composite outcome occurred in 545 (11.4%) derivation cohort participants (n=4,767) and 7 variables were predictors of the primary composite outcome: body mass index, chronic respiratory disease, respiratory rate, resting dyspnea, hemoglobin, sodium, and blood urea nitrogen (c index=0.633, Hosmer-Lemeshow P=.823). In the validation cohort (n=666), 87 (13.1%) events occurred (c index=0.629, Hosmer-Lemeshow P=.386) and adding ischemic heart failure, troponin, and B-type natriuretic peptide improved model performance (net reclassification index 0.79, 95% CI 0.046-0.512; integrated discrimination improvement 0.014, 95% CI 0.005-0.0238). The final 10-variable clinical prediction model demonstrated modest discrimination (c index=0.702) and good calibration (Hosmer-Lemeshow P=.547).
Conclusions: We derived, validated, and improved upon a clinical prediction model in an international trial and a community-based cohort of AHF. The model has modest discrimination; however, these findings deserve further exploration because they may provide a more accurate means of triaging level of care for patients with AHF who need admission.
Jia D, Ji C, Zhao M World J Emerg Med. 2021; 12(4):261-267.
PMID: 34512821 PMC: 8390349. DOI: 10.5847/wjem.j.1920-8642.2021.04.002.
Assessment of acute heart failure prognosis: the promising role of prognostic models and biomarkers.
Kadoglou N, Parissis J, Karavidas A, Kanonidis I, Trivella M Heart Fail Rev. 2021; 27(2):655-663.
PMID: 34036472 DOI: 10.1007/s10741-021-10122-9.
Kanda M, Tateishi K, Nakagomi A, Iwahana T, Okada S, Kuwabara H PLoS One. 2021; 16(5):e0251505.
PMID: 33970971 PMC: 8109822. DOI: 10.1371/journal.pone.0251505.
Freitas C, Wang X, Ge Y, Ross H, Austin P, Pang P CJC Open. 2020; 2(3):135-144.
PMID: 32462127 PMC: 7242506. DOI: 10.1016/j.cjco.2020.02.007.